Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (CA3007503) METHOD AND SYSTEM FOR CHARACTERIZATION OF CLOSTRIDIUM DIFFICILE-ASSOCIATED CONDITIONS

Office : Canada
Application Number: 3007503 Application Date:
Publication Number: 3007503 Publication Date: 15.06.2017
Publication Kind : A1
Prior PCT appl.: Application Number:PCTUS2016065993 ; Publication Number: Click to see the data
IPC:
A61K 38/08
A61P 31/04
A61P 43/00
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
04
Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
08
Peptides having 5 to 11 amino acids
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
04
Antibacterial agents
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
43
Drugs for specific purposes, not provided for in groups A61P1/-A61P41/108
Applicants: UBIOME, INC.
Inventors:
Priority Data: 15/097,862 13.04.2016 US
62/265,077 09.12.2015 US
Title: (EN) METHOD AND SYSTEM FOR CHARACTERIZATION OF CLOSTRIDIUM DIFFICILE-ASSOCIATED CONDITIONS
(FR) PROCEDE ET SYSTEME DE CARACTERISATION D'AFFECTIONS ASSOCIEES A CLOSTRIDIUM DIFFICILE
Abstract: front page image
(EN) An embodiment of a system and method for characterizing a Clostridium-associated condition in relation to a user includes: a handling network operable to receive containers including material from a set of users, the handling network including a sequencing system operable to determine microbiome sequences from sequencing the material; a processing system operable to generate a microbiome composition dataset and a microbiome functional diversity dataset based on the microbiome sequences, receive a supplementary dataset associated with the Clostridium-associated condition for the set of users; transform the supplementary dataset and features extracted from the microbiome composition dataset and the microbiome functional diversity dataset into a characterization model for the Clostridium-associated condition; and a therapy system operable to promote a therapy to the user based on characterizing the user in relation to the Clostridium-associated condition using the characterization model.